mRNA 1083
Alternative Names: COVID+Flu vaccine - Moderna Therapeutics; mRNA-1083; mRNA-1083.1; mRNA-1083.2; mRNA-1083.3; Seasonal flu + COVID combination vaccine - Moderna TherapeuticsLatest Information Update: 31 Dec 2025
At a glance
- Originator Moderna Therapeutics
- Class COVID-19 vaccines; Influenza virus vaccines; RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration COVID 2019 infections; Influenza virus infections
Most Recent Events
- 20 Nov 2025 Preregistration for COVID-2019 infections (Prevention) in Canada (IM) prior to November 2025
- 20 Nov 2025 Preregistration for COVID-2019 infections (Prevention) in European Union (IM) prior to November 2025
- 20 Nov 2025 Preregistration for Influenza virus infections (Prevention) in Canada (IM) prior to November 2025